Recombinant Mouse TFPI cell lysate
Cat.No. : | TFPI-2843MCL |
Product Overview : | Mouse TFPI / LACI / EPI derived in Human Cells. The whole cell lysate is provided in 1X Sample Buffer.Browse all transfected cell lysate positive controls |
- Specification
- Gene Information
- Related Products
Source : | Human cells |
Species : | Mouse |
Preparation method : | Transfected cells were cultured for 48hrs before collection. The cells were lysed in modified RIPA buffer with cocktail of protease inhibitors. Cell debris was removed by centrifugation and then centrifuged to clarify the lysate. The cell lysate was boiled for 5 minutes in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% b-mercaptoethanol, and lyophilized. |
Lysis buffer : | Modified RIPA Lysis Buffer: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 1mM PMSF |
Quality control Testing : | 12.5% SDS-PAGE Stained with Coomassie Blue |
Recommended Usage : | 1. Centrifuge the tube for a few seconds and ensure the pellet at the bottom of the tube.2. Re-dissolve the pellet using 200μL pure water and boiled for 2-5 min.3. Store it at -80°C. Recommend to aliquot the cell lysate into smaller quantities for optimal storage. Avoid repeated freeze-thaw cycles.Notes:The lysate is ready to load on SDS-PAGE for Western blot application. If dissociating conditions are required, add reducing agent prior to heating. |
Stability : | Samples are stable for up to twelve months from date of receipt at -80°C |
Storage Buffer : | 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% SDS, 1% Sodium deoxycholate, 1mM PMSF |
Storage Instruction : | Lysate samples are stable for 12 months from date of receipt when stored at -80°C. Avoid repeated freeze-thaw cycles. Prior to SDS-PAGE fractionation, boil the lysate for 5 minutes. |
Gene Name : | Tfpi tissue factor pathway inhibitor [ Mus musculus ] |
Official Symbol : | TFPI |
Synonyms : | TFPI; tissue factor pathway inhibitor; extrinsic pathway inhibitor; lipoprotein-associated coagulation inhibitor; EPI; LACI; AW552122; A630013F22Rik; |
Gene ID : | 21788 |
mRNA Refseq : | NM_001177319 |
Protein Refseq : | NP_001170790 |
Pathway : | Complement and Coagulation Cascades, organism-specific biosystem; Complement and coagulation cascades, organism-specific biosystem; Complement and coagulation cascades, conserved biosystem; Extrinsic Pathway, organism-specific biosystem; Formation of Fibrin Clot (Clotting Cascade), organism-specific biosystem; Hemostasis, organism-specific biosystem; |
Function : | peptidase inhibitor activity; serine-type endopeptidase inhibitor activity; |
Products Types
◆ Recombinant Protein | ||
TFPI-707H | Recombinant Human TFPI Protein, MYC/DDK-tagged | +Inquiry |
Tfpi-6383M | Recombinant Mouse Tfpi Protein, Myc/DDK-tagged | +Inquiry |
Tfpi-9155M | Recombinant Mouse Tfpi Protein, His (Fc)-Avi-tagged | +Inquiry |
TFPI-752H | Recombinant Human TFPI Protein | +Inquiry |
Tfpi-981M | Active Recombinant Mouse Tfpi protein(Met1-Lys289), His-tagged | +Inquiry |
◆ Lysates | ||
TFPI-2746HCL | Recombinant Human TFPI cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionMonitoring TFPI levels is crucial in patients with a history of thrombotic events, individuals at high risk of clotting disorders, and those undergoing anticoagulant therapy.
Research suggests that manipulating TFPI levels might be explored to reduce thrombotic complications in surgical and medical settings, potentially improving patient outcomes.
Manipulating TFPI levels may pose challenges, as it could potentially lead to bleeding disorders. Balancing the anticoagulant effects with the risk of bleeding is a critical consideration.
TFPI has anti-inflammatory effects by inhibiting the activation of immune cells and downregulating inflammatory mediators. This dual role makes it a potential therapeutic target in conditions involving both coagulation and inflammation.
Pharmaceutical research can explore the development of drugs that either enhance or mimic the activity of TFPI, providing new avenues for anticoagulant therapies.
Customer Reviews (3)
Write a reviewThis property is particularly beneficial for long-term trials or experiments with extended durations, ensuring consistent performance throughout the entire study period.
Its purity and consistency have been extensively validated, minimizing any potential variability that could affect trial outcomes.
Their extensive technical expertise and assistance are invaluable in overcoming any challenges that may arise during the experimental process.
Ask a Question for All TFPI Products
Required fields are marked with *
My Review for All TFPI Products
Required fields are marked with *
Inquiry Basket